GRA
CTVA icon

Goehring & Rozencwajg Associates’s Corteva CTVA Stock Holding History

Goehring & Rozencwajg Associates’s Portfolio CTVA Stock Details CTVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-95,257
Closed -$5.6M – 45
2024
Q3 		$5.6M Buy
95,257
+6,472
+7% +$353K 1.14% 34
2024
Q2 		$4.79M Buy
88,785
+8,600
+11% +$474K 0.95% 36
2024
Q1 		$4.62M Buy
80,185
+5,500
+7% +$284K 1% 36
2023
Q4 		$3.58M Buy
74,685
+2,330
+3% +$111K 0.86% 36
2023
Q3 		$3.7M Buy
72,355
+2,300
+3% +$122K 0.91% 35
2023
Q2 		$4.01M Buy
70,055
+836
+1% +$48.8K 1.15% 34
2023
Q1 		$4.17M Buy
69,219
+2,976
+4% +$182K 1.42% 26
2022
Q4 		$3.89M Buy
+66,243
New +$4.19M 1.38% 26

Other funds holding CTVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IFP
Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Goehring & Rozencwajg Associates's CTVA Position: Q4 2024 in Review

Goehring & Rozencwajg Associates sold out of Corteva (CTVA) in Q4 2024, closing a stake of 95,257 shares — an estimated $5.6M sold.

Goehring & Rozencwajg Associates first reported a position in CTVA in Q4 2022 and held it in 8 quarters. The position peaked at $5.6M in Q3 2024. 1,299 funds tracked by Wall St. Rank hold CTVA as of Q4 2024.

  • Goehring & Rozencwajg Associates reported no remaining Corteva position as of Q4 2024 after selling out during the quarter.
  • Goehring & Rozencwajg Associates sold 95,257 Corteva shares in Q4 2024, an estimated $5.6M.
  • Goehring & Rozencwajg Associates first reported a position in Corteva in Q4 2022 and held it in 8 quarters.
  • Goehring & Rozencwajg Associates's Corteva position peaked at $5.6M in Q3 2024.
  • 1,299 funds tracked by Wall St. Rank held Corteva as of Q4 2024.

Based on Goehring & Rozencwajg Associates's 13F filing for Q4 2024, filed 28 Jan 2025.